ARTICLE | Company News
Helsinn, Zealand Pharma deal
January 9, 2012 8:00 AM UTC
Zealand received a €3 million ($3.9 million) milestone payment from Helsinn under a 2008 deal granting Helsinn an exclusive, worldwide license to develop and commercialize elsiglutide ( ZP1846). The m...